Drreddys Laboratories | Passività Correnti



Current Liabilities Cambiamento Data
ANI Pharmaceuticals USD 193.68M 3.75M 2024-12
Aurora Cannabis CAD 149.81M 40.71M 2024-12
Bayer EUR 28.95B 3.9B 2024-12
Canopy Growth CAD 97.02M 184.27M 2024-12
Cipla INR 54.55B 2.09B 2024-09
Corcept Therapeutics USD 140.77M 14.56M 2024-12
Drreddys Laboratories INR 131.95B 2.65B 2024-12
GlaxoSmithKline GBP 21.7B 238M 2024-12
Hikma Pharmaceutical USD 1.38B 41M 2024-06
Lonza CHF 3.58B 970M 2024-12
Novartis USD 28.69B 560M 2024-12
Pacira USD 309.92M 3.52M 2024-12
Prestige Brands USD 102.54M 4.36M 2024-12
Richter Gedeon HUF 175.24B 34.29B 2024-12
Sun Pharmaceuticals INR 172.55B 2.71B 2024-09
Supernus Pharmaceuticals USD 292.4M 889K 2024-12
Teva Pharmaceutical Industries USD 12.8B 1B 2024-12



Drreddys Laboratories Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.